AZBio in the Loop for the Week of March 27, 2017


Arizona Bioscience Week Proclamation in the Senate
Wednesday, March 22, 2017, Senator Nancy Barto, Health and Human Services Committee Chair, recognized the  work of our researchers, educators, innovators, and healthcare professionals and proclaimed the Week of October 8, 2017 as Arizona Bioscience Week.  

Congresswoman Sinema Introduces Fostering Innovation Act

On March 22, 2017, Congresswoman Kyrsten Sinema (AZ-09) and Congressman Trey Hollingsworth (IN-09) introduced the Fostering Innovation Act, bipartisan legislation to provide commonsense regulatory relief for companies on the cutting edge of scientific and medical research.

DEA Schedules Insys Therapeutics’ Syndros (dronabinol oral solution) as Schedule II Drug

On March 23, 2017, Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or the “Company”)  announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II of the Controlled Substances Act.

HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU

HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has obtained CE marking in the European Union for its HTG EdgeSeq ALKPlus Assay EU.

Critical Path Institute launches type 1 diabetes consortium

Critical Path Institute (C-Path) announced the launch of the Type 1 Diabetes (T1D) Consortium. Funded by The Leona M. and Harry B. Helmsley Charitable Trust; Janssen Research & Development, LLC; JDRF International; and Sanofi.

Castle Biosciences’ DecisionDx-Melanoma Test Shown to be a Significant Predictor of Distant Metastasis in Elderly Patients with Melanoma

Additional independent studies presented at the 70th Society of Surgical Oncology Annual Cancer Symposium confirm performance and clinical impact of test. 

NASA, ASU collaboration develops new 3-D tissue culture models with immune cells to better mimic human gut infections

The study was led by Cheryl Nickerson, along with co-authors Jennifer Barrila and Jiseon Yang.

Do YOU have news to share with our community?  

Send your news and events to

Maintaining and growing our university research infrastructure is key to growing our industry and our state. Please send AZBio your letter on why you support Governor Ducey’s plan to invest $1 Billion dollars in our University Research Infrastructure and AZBio will deliver it to the Capitol  along with the letters we are collecting from leaders across the state.

Click the links to download the letter template and fact sheet.   

Click here to send an email to YOUR legislators.  Your voice matters! 

– Events  – Committees – Savings
March 28th and 29th  
This event is Sold Out! 

Upcoming Events

Molecular, Cellular and Tissue Bioengineering Symposium

  • Apr 1, 2017 – Tempe

Mini Med School: The War on Cancer

  • Apr 5, 2017 – Phoenix

Cord Blood Conference: Blazing Frontiers

  • Apr 13, 2017 – Phoenix

2017 BIO International Convention

  • Jun 19, 2017 – San Diego

Rocky Mountain Life Science Investor and Partnering Conference

  • Oct 2, 2017 – Vail – Apply to Present Today!

Save the date – our next AZBio Government Affairs Committee call is

 Thursday, April 13th at 3 PM AZ/PDT

All AZBio Members are welcome to join the AZBio Government Affairs Committee. 

 Click here to be added to the committee 

The AZBio Legislative Watch List  contains information on bills that impact our industry at the Arizona Legislature.  The list is updated weekly and posted on under the Advocacy tab.  View the AZBio Watch List

AZBio Leadership will be traveling to Washington DC to meet with our Congressional Delegation on April 4-5.  Want to join us in DC?

  Contact AZBio to learn more. 


Join  AZBio

AZBio is committed to making
Arizona a Top Tier Bioscience State. 
AZBio Members are making it happen!View AZBio Member Directory
To learn more about AZBio click here     

 Thank you to our AZBio Supporters

Legacy Level:  Arizona Commerce Authority * Dorn Policy Group * Flinn Foundation
Chairman’s Circle:  Johnson & Johnson * Roche 
Leadership Level:  Amanda Vega Consulting * Amgen * BIO * BusinessWire *City of Scottsdale * City of Tempe * Cord Blood Registry (CBR) * Genentech  * Janssen Biotech * KCA * Medtronic Tempe Campus * New Angle Media * Pfizer * Pinnacle Transplant Technologies * Roche Diagnostics * Snell & Wilmer * The Biodesign Institute at ASU * UA BIO5 * Ulthera * University of Arizona * Ventana Medical Systems * VWR   
Sustaining Partners:  AdvaMed  * Alliance Bank of Arizona * Affordable Image * Allergan * Airgas * Bank of America * Bristol-Myers Squibb * Dignity Health * Eli Lilly * EY * International Research Center * Merrill Lynch * Northern Arizona University * PADT Medical * U.S. Trust  
AZBio Supporters make what we do possible.  Download the AZBio Prospectus to learn more. 


Posted in AZBio News, In the Loop.